Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 11959
TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665293(US20240116893, Compound 7)
Affinity DataIC50: 1.60nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665295(US20240116893, Compound 9)
Affinity DataIC50: 1.70nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665292(US20240116893, Compound 6)
Affinity DataIC50: 2.40nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665291(US20240116893, Compound 5)
Affinity DataIC50: 2.5nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665290(US20240116893, Compound 4)
Affinity DataIC50: 2.60nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665289(US20240116893, Compound 3)
Affinity DataIC50: 2.80nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665288(US20240116893, Compound 1 | US20240116893, Compoun...)
Affinity DataIC50: 3.10nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665295(US20240116893, Compound 9)
Affinity DataIC50: 4.20nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665293(US20240116893, Compound 7)
Affinity DataIC50: 8.20nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665289(US20240116893, Compound 3)
Affinity DataIC50: 8.5nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665288(US20240116893, Compound 1 | US20240116893, Compoun...)
Affinity DataIC50: 9nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665288(US20240116893, Compound 1 | US20240116893, Compoun...)
Affinity DataIC50: 29nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group C member 2(Human)
Duke University

US Patent
LigandPNGBDBM665296(US20240116893, Compound 10)
Affinity DataIC50: 32nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665290(US20240116893, Compound 4)
Affinity DataIC50: 48nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665288(US20240116893, Compound 1 | US20240116893, Compoun...)
Affinity DataIC50: 120nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665292(US20240116893, Compound 6)
Affinity DataIC50: 402nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665296(US20240116893, Compound 10)
Affinity DataIC50: 1.12E+3nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Duke University

US Patent
LigandPNGBDBM665291(US20240116893, Compound 5)
Affinity DataIC50: 2.50E+3nMAssay Description:Accordingly, the present disclosure is directed to the use of these compounds in the preparation and execution of screening assays for compounds whic...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent